Novo Nordisk Total Current Liabilities 2010-2024 | NVO

Novo Nordisk total current liabilities for the quarter ending December 31, 2024 were $31.542B, a 28.04% increase year-over-year.

  • Novo Nordisk total current liabilities for 2024 were $31.542B, a 28.04% increase from 2023.
  • Novo Nordisk total current liabilities for 2023 were $24.634B, a 43.85% increase from 2022.
  • Novo Nordisk total current liabilities for 2022 were $17.125B, a 8.16% increase from 2021.

Novo Nordisk Total Current Liabilities 2010-2024 | NVO

  • Novo Nordisk total current liabilities for 2024 were $31.542B, a 28.04% increase from 2023.
  • Novo Nordisk total current liabilities for 2023 were $24.634B, a 43.85% increase from 2022.
  • Novo Nordisk total current liabilities for 2022 were $17.125B, a 8.16% increase from 2021.
Related Stocks
Company NameMarket
Cap
Eli Lilly (LLY)$823.1B
Johnson & Johnson (JNJ)$380.1B
AbbVie (ABBV)$348.4B
Roche Holding AG (RHHBY)$259.5B
Novartis AG (NVS)$218.5B
Merck (MRK)$216.5B
Pfizer (PFE)$146.7B
Sanofi (SNY)$136B
Bayer (BAYRY)$22B
Innoviva (INVA)$1.1B